Drug discovery

The process of drug discovery is paramount in identifying and characterising molecules that have the the ability to safely modulate disease. The new Novel molecules normally have increase toxicity or unknown detrimental effects to humans. ONFAB's isolator range can assist in the process of providing the levels of safety needed to support the growth and development of these new life saving treatments.

With strong competition and a dynamic regulatory environment, organisations developing their laboratory facilities need to retain ultimate flexibility whilst complying with GLP or GMP standards. Premium quality equipment that will support high precision work and provide ultra-clean air environments is an essential part of the lab toolkit.

High containment for CMOs

For contract manufacturing organisations (CMOs) specialising in GMP manufacture and sterile fill-finish of vials for clinical trials or low volume commercial supply, we offer a wide range of containment solutions.

Our portfolio of isolators is designed to protect users and product when filling biological pharmaceutical products such as antibodies, proteins, peptides, DNAs, RNAs, ADCs and cytotoxic, cytostatic and high potent APIs.

What's more, despite the niche nature of many of these therapeutics, our solutions can support continuous as well as batch processing, as well as the rapid change out between high potent and non-potent compounds.